170 related articles for article (PubMed ID: 33758848)
1. One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening.
Urdaniz IF; Steiner PJ; Kirby MB; Zhao F; Haas CM; Barman S; Rhodes ER; Peng L; Sprenger KG; Jardine JG; Whitehead TA
bioRxiv; 2021 Mar; ():. PubMed ID: 33758848
[TBL] [Abstract][Full Text] [Related]
2. One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening.
Francino-Urdaniz IM; Steiner PJ; Kirby MB; Zhao F; Haas CM; Barman S; Rhodes ER; Leonard AC; Peng L; Sprenger KG; Jardine JG; Whitehead TA
Cell Rep; 2021 Aug; 36(9):109627. PubMed ID: 34416153
[TBL] [Abstract][Full Text] [Related]
3. A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants.
Haslwanter D; Dieterle ME; Wec AZ; O'Brien CM; Sakharkar M; Florez C; Tong K; Rappazzo CG; Lasso G; Vergnolle O; Wirchnianski AS; Bortz RH; Laudermilch E; Fels JM; Mengotto A; Malonis RJ; Georgiev GI; Quiroz JA; Wrapp D; Wang N; Dye KE; Barnhill J; Dye JM; McLellan JS; Daily JP; Lai JR; Herbert AS; Walker LM; Chandran K; Jangra RK
mBio; 2021 Oct; 12(5):e0247321. PubMed ID: 34607456
[TBL] [Abstract][Full Text] [Related]
4. Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.
Rochman ND; Faure G; Wolf YI; Freddolino PL; Zhang F; Koonin EV
mBio; 2022 Apr; 13(2):e0013522. PubMed ID: 35289643
[TBL] [Abstract][Full Text] [Related]
5. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
Yi C; Sun X; Lin Y; Gu C; Ding L; Lu X; Yang Z; Zhang Y; Ma L; Gu W; Qu A; Zhou X; Li X; Xu J; Ling Z; Xie Y; Lu H; Sun B
Genome Med; 2021 Oct; 13(1):164. PubMed ID: 34649620
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Deep Mutational Scanning Reveals the Immune-Escaping Hotspots of SARS-CoV-2 Receptor-Binding Domain Targeting Neutralizing Antibodies.
Tsai KC; Lee YC; Tseng TS
Front Microbiol; 2021; 12():698365. PubMed ID: 34335530
[TBL] [Abstract][Full Text] [Related]
8. Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein.
Van Egeren D; Novokhodko A; Stoddard M; Tran U; Zetter B; Rogers M; Pentelute BL; Carlson JM; Hixon M; Joseph-McCarthy D; Chakravarty A
PLoS One; 2021; 16(4):e0250780. PubMed ID: 33909660
[TBL] [Abstract][Full Text] [Related]
9. Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD.
Peter AS; Grüner E; Socher E; Fraedrich K; Richel E; Mueller-Schmucker S; Cordsmeier A; Ensser A; Sticht H; Überla K
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897753
[TBL] [Abstract][Full Text] [Related]
10. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
11. Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape.
Rochman ND; Faure G; Wolf YI; Freddolino PL; Zhang F; Koonin EV
bioRxiv; 2021 Dec; ():. PubMed ID: 34494024
[TBL] [Abstract][Full Text] [Related]
12. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
Front Immunol; 2021; 12():691715. PubMed ID: 34149735
[TBL] [Abstract][Full Text] [Related]
13. Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants.
Mittal A; Khattri A; Verma V
PLoS Pathog; 2022 Feb; 18(2):e1010260. PubMed ID: 35176090
[TBL] [Abstract][Full Text] [Related]
14. Key residues of the receptor binding domain in the spike protein of SARS-CoV-2 mediating the interactions with ACE2: a molecular dynamics study.
Yang Y; Zhang Y; Qu Y; Zhang C; Liu XW; Zhao M; Mu Y; Li W
Nanoscale; 2021 May; 13(20):9364-9370. PubMed ID: 33999091
[TBL] [Abstract][Full Text] [Related]
15. Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines.
Cao Y; Yisimayi A; Bai Y; Huang W; Li X; Zhang Z; Yuan T; An R; Wang J; Xiao T; Du S; Ma W; Song L; Li Y; Li X; Song W; Wu J; Liu S; Li X; Zhang Y; Su B; Guo X; Wei Y; Gao C; Zhang N; Zhang Y; Dou Y; Xu X; Shi R; Lu B; Jin R; Ma Y; Qin C; Wang Y; Feng Y; Xiao J; Xie XS
Cell Res; 2021 Jul; 31(7):732-741. PubMed ID: 34021265
[TBL] [Abstract][Full Text] [Related]
16. Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding.
Bozdaganyan ME; Shaitan KV; Kirpichnikov MP; Sokolova OS; Orekhov PS
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215888
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.
Barnes CO; Jette CA; Abernathy ME; Dam KA; Esswein SR; Gristick HB; Malyutin AG; Sharaf NG; Huey-Tubman KE; Lee YE; Robbiani DF; Nussenzweig MC; West AP; Bjorkman PJ
Nature; 2020 Dec; 588(7839):682-687. PubMed ID: 33045718
[TBL] [Abstract][Full Text] [Related]
20. Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display.
Tanaka S; Olson CA; Barnes CO; Higashide W; Gonzalez M; Taft J; Richardson A; Martin-Fernandez M; Bogunovic D; Gnanapragasam PNP; Bjorkman PJ; Spilman P; Niazi K; Rabizadeh S; Soon-Shiong P
Cell Rep; 2022 Feb; 38(6):110348. PubMed ID: 35114110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
